Published On: Wed, Oct 19th, 2016

Recently Changed Price Targets On Humana Inc. (NYSE:HUM)


A number of investment brokers have recently updated their price targets on shares of Humana Inc. (NYSE:HUM).

Most recent broker ratings

10/13/2016 – Humana Inc. had its “sector perform” rating reiterated by analysts at RBC Capital. They now have a USD 217 price target on the stock.

10/13/2016 – Humana Inc. had its “equal weight” rating reiterated by analysts at Barclays. They now have a USD 191 price target on the stock.

10/12/2016 – Humana Inc. had its “neutral” rating reiterated by analysts at Susquehanna. They now have a USD 180 price target on the stock.

09/22/2016 – Evercore ISI began new coverage on Humana Inc. giving the company a “buy” rating. They now have a USD 200 price target on the stock.

08/22/2016 – Humana Inc. had its “hold” rating reiterated by analysts at Argus.

08/16/2016 – Humana Inc. had its “neutral” rating reiterated by analysts at Credit Suisse. They now have a USD 188 price target on the stock.

07/22/2016 – Humana Inc. had its “mkt perform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 170 price target on the stock.

07/22/2016 – Humana Inc. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 220 price target on the stock.

07/21/2016 – Humana Inc. was upgraded to “outperform” by analysts at Wolfe Research. They now have a USD 192 price target on the stock.

07/08/2016 – Humana Inc. was downgraded to “neutral” by analysts at JP Morgan. They now have a USD 150 price target on the stock.

06/20/2016 – Humana Inc. had its “outperform” rating reiterated by analysts at Leerink Swann.

06/07/2016 – Humana Inc. had its “neutral” rating reiterated by analysts at UBS. They now have a USD 199 price target on the stock.

05/05/2016 – Humana Inc. had its “buy” rating reiterated by analysts at Stifel Nicolaus. They now have a USD 220 price target on the stock.

04/05/2016 – Humana Inc. had its “outperform” rating reiterated by analysts at Cowen.

07/06/2015 – Humana Inc. had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 230 price target on the stock.

The share price of Humana Inc. (NYSE:HUM) was up +1.99% during the last trading session, with a day high of 174.10. 908125 shares were traded on Humana Inc.’s last session.

The stock’s 50 day moving average is 175.62 and its 200 day moving average is 175.43. The stock’s market capitalization is 25.83B. Humana Inc. has a 52-week low of 150.00 and a 52-week high of 191.65.

Humana Inc. is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only products. The Healthcare Services segment includes services, such as pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies.